Skip to main content
Smart Investors Daily
IT

OTC · ITNS

Itonis, Inc.

Healthcare · Medical - Distribution

$0.00

Down-$0.00 (-25.00%)

Updated Sep 17, 2026, 12:16 PM

SID Score

3.0/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
457.02K
P/E ratio
-46.21
Dividend yield
0.00%
52-week range
$0.00 – $0.00
Volume
1M
Avg. volume
845.57K

Price performance

ITNS price history

1M range · 8 trading sessions · Daily adjusted prices

ITNS closed at $0.00 after 8 trading sessions, up 0.00% for the selected period.

Last close
$0.00
Period change
+0.00%
Period low
$0.00
Period high
$0.00
Daily close
View OHLC price history
ITNS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 16, 2026$0.0003$0.0004$0.0003$0.00041M
Sep 15, 2026$0.0004$0.0004$0.0004$0.00042.66K
Sep 14, 2026$0.0003$0.0003$0.0003$0.00031M
Sep 4, 2026$0.0003$0.0004$0.0003$0.0004102.66K
Aug 26, 2026$0.0003$0.0004$0.0003$0.00041M
Aug 25, 2026$0.0003$0.0004$0.0003$0.00043.16K
Aug 24, 2026$0.0003$0.0004$0.0003$0.0004505.32K
Aug 21, 2026$0.0003$0.0004$0.0003$0.0004202.66K

Latest ITNS news

The latest Smart Investors Daily articles mentioning ITNS.

ITNS research

Overview

Company profile and research snapshot.

Company profile

ITONIS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jan 5, 2026

Caring Brands Announces Exclusive Global License to Manufacture and Market Emesyl

Jupiter, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (Nasdaq: CABR) today announced that it has entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and distribute Emesyl, Itonis’s over-the-counter (OTC) nausea relief product. The agreement provides Caring Brands with full rights to commercialize Emesyl and to oversee all manufacturing activities associated with the product. Under the terms of the agreement, Caring Brands will assume respo

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.